Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 2,481 followers.

RT @COVID_Evidence: PubMed: Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated sys…

10 Feb 2023

Reply Repost Favourite

PubMed: Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis: CONCLUSIONS: Results of this study suggest that severe hospitalized… https://t.co/JDaD2osKAB #covid19 #

09 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.